Sentences with phrase «on tumor biology»

Cancer researchers are generating mounds of molecular data on tumor biology.

Not exact matches

We're also making progress on our liquid biopsy program since our last update, including the recently announced collaboration with Memorial Sloan Kettering Cancer Center, which is focused on furthering the basic understanding of the biology of circulating tumor DNA, or ctDNA, in different cancer types.
«The tumor cells are smart,» said Wei Guo, co-corresponding author on the study and a professor of biology in Penn's School of Arts and Sciences.
In addition to formulating diagnostic strategies for cancer immunotherapy agents, her team is focused on developing a deep understanding of tumor immune biology as well as mechanisms associated with immune response and immune escape in cancer patients, with the intent of generating rational strategies for the creation of combination therapies.
«If you can get a better handle on the biology of the primary tumor, and the elements of the tumor that may be more or less dangerous, then you don't need to worry about testing every single metastasis for treatment decisions.»
Dr. Yaffe's research focuses on the biology of the complex signaling pathways that cells use to respond to DNA damage and inflammation, particularly the role of protein kinases and modular binding domains in tumor development and anti-cancer therapeutics.
Future oncologists will need to have a much deeper understanding of tumor biology on a molecular level than their predecessors.
By shedding light on subtle distinctions in tumor biology, these findings offer clues to designing more effective anticancer treatments to precisely target tumors in individual patients.
We are just beginning to understand the biology underpinning NSAID use on the tumor's molecular pathways, and it's very exciting.»
Of note, the current study is part of a recent surge in NYU Langone findings on pancreatic cancer, including studies on how first - responder cells turn off the immune response, the role of the drug nab - paclitaxel in tumor biology, cancer cells» unique fuel sources, and how immune cell infighting drives the disease.
NEW YORK and SEATTLE — April 5, 2018 — The Cancer Research Institute (CRI), Institute for Systems Biology (ISB) and Sage Bionetworks — three organizations on the forefront of cancer immunotherapy, systems biology and bioinformatics — today announced the release of the Cancer Research Institute iAtlas, a comprehensive web - based tool that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment.
Although extensive efforts have been devoted to understanding the effect of hypoxia on tumor progression, two areas of tumor biology remain unclear.
In addition to her expertise in tumor biology and a broad network of connections with leading scientists and clinicians in cancer research and clinical oncology, Dr. Almog has extensive hands - on experience with a variety of techniques ranging from the molecular level (DNA, RNA and proteins) to tissue, organ and mouse models in cancer biology, as well as extensive experience in project management and program coordination.
During his 11 years of extensive work experience in the fields of cell and cancer biology (including work on the famous tumor suppressor gene BRCA1), and biochemistry he has successfully published in peer - reviewed journals such as Molecular and Cell Biology and Cancer Research.
In my own lab here at Indiana University School of Medicine, I am bringing some of those chemical biology techniques to bear on problems in eye disease and we continue to work on tumors of the eye, but we also developed a major focus on neovascular eye diseases, including wet, age - related macular degeneration (AMD).
CSC hypothesis has resulted in incredible impact on the understanding and insight into tumor biology.
Using expertise in genomics and cell biology, Dr. Pillai is looking forward to expanding his research in the field of Tumor Immunology, with focus on Breast Cancer.
Michael Nolan, assistant professor of radiation oncology and biology, received $ 23,060 for a study on using enhanced ethanol ablation, or direct ethanol injections to reduce tumors, as a lower - cost treatment for oral cancer.
Michael Nolan, assistant professor of radiation oncology and biology, received $ 23,060 for a study on using enhanced ethanol ablation, or direct ethanol injections to reduce tumors, as a
In the last 10 years, we've invested just over $ 150,000 in seven studies focused specifically on squamous cell carcinoma, melanoma, and sarcoid tumor biology and treatment.
a b c d e f g h i j k l m n o p q r s t u v w x y z